As of Jun 24
| -0.1814 / -4.56%|
The 7 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 7.05, with a high estimate of 17.64 and a low estimate of 3.00. The median estimate represents a +85.41% increase from the last price of 3.80.
The current consensus among 8 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.